Cargando…
Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease
Patients with chronic obstructive pulmonary disease (COPD) are often at high risk of early death. Identification of prognostic biomarkers for COPD may aid in improving their survival by providing early strengthened therapy for high-risk patients. In the present study, we investigated the prognostic...
Autores principales: | Zhang, Xin, Liu, Lijie, Liang, Rui, Jin, Shoude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664430/ https://www.ncbi.nlm.nih.gov/pubmed/26648710 http://dx.doi.org/10.2147/COPD.S87202 |
Ejemplares similares
-
Associations of ABHD2 Genetic Variations with Risks for Chronic Obstructive Pulmonary Disease in a Chinese Han Population
por: Liu, Li, et al.
Publicado: (2015) -
Machine-Learning Algorithm-Based Prediction of Diagnostic Gene Biomarkers Related to Immune Infiltration in Patients With Chronic Obstructive Pulmonary Disease
por: Zhang, Yuepeng, et al.
Publicado: (2022) -
Hyperuricemia Is Not Predictive of Long-Term Outcome in Patients with Stable Chronic Obstructive Pulmonary Disease
por: Hwang, Jae-Joon, et al.
Publicado: (2020) -
nCD64 index as a prognostic biomarker for mortality in acute exacerbation of chronic obstructive pulmonary disease
por: Xu, Ning, et al.
Publicado: (2016) -
Reducing chronic obstructive pulmonary disease mortality in Korea: early diagnosis matters
por: Hwang, Yong Il
Publicado: (2019)